October 8, 2024

D-VRd Propels Toward SOC Status in Transplant-Ineligible, Newly Diagnosed Multiple Myeloma – OncLive

October 7, 2024

Discontinuation of maintenance therapy in multiple myeloma guided by multimodal measurable residual disease negativity (MRD2STOP) – Nature.com

October 5, 2024

Multiple Myeloma: Michael’s Story – BMT Infonet |

October 5, 2024

Allogeneic CAR T-Cell Therapy Is Safe, Effective in Heavily Pretreated Myeloma – www.oncnursingnews.com/

October 2, 2024

Early Results from Multiple Myeloma Clinical Trial Prove Cancer Drug Combination Provides Longer Response and Potential Benefit in Disease-Free Survival – University of Maryland School of Medicine